The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

pharmacopeia.com

Founded Year

1993

Stage

PIPE | IPO

About Pharmacopeia

Pharmacopeia is a Healthcare/Pharmaceuticals / Drugs company based in Cranbury, New Jersey. Pharmacopeia's investors include Fifth Third Bank, Crestview Capital Funds, Carpe Diem Capital Management, Nite Capital Management, Clarion Capital Partners, Downsview Capital, Sangamon Trading, Iroquois Capital, BVF, Highbridge Capital Management, Balyasny Asset Management and Rima Management.

Pharmacopeia Headquarter Location

3000 Eastpark Boulevard

Cranbury, New Jersey, 08512,

United States

609-452-3600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Pharmacopeia Patents

Pharmacopeia has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/13/2007

8/23/2011

Psychiatric diagnosis, Beta blockers, Phenols, Phenethylamines, Neurotransmitters

Grant

Application Date

2/13/2007

Grant Date

8/23/2011

Title

Related Topics

Psychiatric diagnosis, Beta blockers, Phenols, Phenethylamines, Neurotransmitters

Status

Grant

Latest Pharmacopeia News

U.S. Pharmacopeia Offers Support for Developers of COVID-19 Antiviral Drugs and Vaccines

Mar 23, 2020

Organizations interested in taking advantage of this resource should contact USP as soon as possible: We call on stakeholders to designate a point of contact from their organization with whom we can discuss how we will work as a community with the goal of creating an environment for enhanced information sharing and partnering to facilitate solutions to address the pandemic. USP will work with stakeholders developing viral testing strategies, antiviral therapies, and vaccines, as well as experts from global regulatory bodies and public health agencies (e.g., Centers of Disease Control, U.S. Food and Drug Administration, World Health Organization). USP scientific teams are prepared to assist with solutions in numerous areas. Examples include: Best practices that are broadly applicable to manufacturing and testing strategies and are aligned with global regulatory guidelines; includes test methods and procedures (e.g., sterility testing, bacterial contamination control) that can be used to manage regulatory expectations; Qualification of excipients and raw materials to be used in manufacturing ; Our collection of USP Reference Standards which contain materials to demonstrate the suitability of the methods and can also be used for the development and validation of analytical methods; Technical assistance to those who are interested in following our processes and use our standards. We are happy to engage in further dialog with stakeholders to ensure that their approaches to analytical methods can meet compendial and regulatory expectations.

  • When was Pharmacopeia founded?

    Pharmacopeia was founded in 1993.

  • Where is Pharmacopeia's headquarters?

    Pharmacopeia's headquarters is located at 3000 Eastpark Boulevard, Cranbury.

  • What is Pharmacopeia's latest funding round?

    Pharmacopeia's latest funding round is PIPE.

  • Who are the investors of Pharmacopeia?

    Investors of Pharmacopeia include Fifth Third Bank, Crestview Capital Funds, Iroquois Capital Group, BVF Partners, Clarion Capital Partners and 13 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.